TrialCirculation2020

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.

Gregory G Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.